Skip to content

Addiction: all studies

Page 207 of 857: studies 2,061 to 2,070 of 8,563, newest first. Back to the addiction overview

Research

Veiled Expressions of the Sacred: Ghazal, Genre, and Mystical Experience in Neshāṭī’s Poetry

Religions March 27, 2026 Muhammed Tarik Ablak

This article examines how religious experience is articulated through genre in the poetry of the seventeenth-century Ottoman Mawlawī shaykh Neshāṭī (d. 1674), focusing on the striking contrast between his ghazals and non-ghazal compositions. While Neshāṭī’s qaṣīdas, mathnawīs and other formal genres employ an explicit and direct religious language—addressing God, the Prophet, sacred figures,...

Effectiveness of Deconstructive Meditative Practices in Improving Mental Health and Well-being: A Systematic Review

Mindfulness March 27, 2026 Paulina Lamas-Morales, Carlos García-rubio, María Beltrán-ruiz et al.

Abstract Objectives Deconstructive meditative practices (DMPs) aim to transform the perception of the self by fostering an understanding of its constructed and impermanent nature through self-inquiry. This systematic review evaluated the effectiveness of DMPs in improving mental health and psychological well-being among adults. Method Following PRISMA guidelines, a comprehensive search was...

DOI: 10.1007/s12671-026-02825-7 (opens in new tab) Full text (opens in new tab) Mindfulness Generalizability theory Mental health Psychological intervention +13

Ketamine as a Rapid-Acting Antidepressant: A Scoping Review of Mechanisms and Efficacy in Treatment-Resistant Depression.

Psychopathology March 27, 2026 Xiaoran Ding, Yaping Wu, Juan Yang et al. 1 citation

Ketamine has emerged as a promising rapid-acting antidepressant with distinct advantages for the treatment of treatment-resistant depression (TRD). Its therapeutic effects are mediated through multi-target modulation of the glutamatergic system. Unlike conventional antidepressants, ketamine exerts a markedly faster onset of action; however, its long-term safety profile and potential risk of...

MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats.

Neuropsychopharmacology March 27, 2026 Kade L Huckstep, Billi Newton, Grace Bailey et al.

Comorbidity between post-traumatic stress disorder (PTSD) and alcohol use is common and mutually-reinforcing, yet there are no pharmacological strategies that specifically target trauma-linked escalation of alcohol intake. We evaluated whether 3,4-methylenedioxymethamphetamine (MDMA), given in a therapy-adjunctive fashion (30 min before fear extinction), could facilitate extinction of...

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants

Translational Psychiatry March 27, 2026 Livio Erne, Lorenz Mueller, Isabelle Straumann et al.

N,N-dimethyltryptamine (DMT) is a serotonergic psychedelic that produces short-lived peak effects when administered intravenously as a bolus dose. Initial trials suggested therapeutic effects of DMT in depressive disorders. However, systematic data on dose-dependent pharmacokinetics and acute effects of intravenous bolus DMT administration are currently lacking. We used a double-blind,...

DOI: 10.1038/s41398-026-03987-7 (opens in new tab) Full text (opens in new tab) Tolerability Pharmacokinetics Crossover study Placebo +7

Classic psychedelic medicines for adolescent refractory mental health disease

Journal of Psychedelic Studies March 26, 2026 Aly Shah Aziz

Abstract Adolescent refractory mental health disorders are rising globally, contributing to long-term morbidity and substantial societal burden. Conventional psychotropic medications and psychotherapeutic approaches sometimes fail to provide adequate relief, necessitating an interest in novel investigational interventions. Classic psychedelic compounds—Psilocybin, Lysergic Acid Diethylamide...

Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD).

Brain Sciences March 26, 2026 Piotr Skalski, Katarzyna Pękacka-falkowska, Agnieszka Pluto-Prądzyńska et al.

Background/Objectives: Psilocybin has re-emerged as a promising intervention for neuropsychiatric disorders including major depressive disorder, treatment-resistant depression, anxiety associated with life-threatening illness, obsessive compulsive disorder, and substance use disorders. However, conventional randomized controlled trials (RCTs)-the current gold standard in evidence-based...

DOI: 10.3390/brainsci16040358 (opens in new tab) Full text (opens in new tab) Evidence Psilocybin-assisted therapy pat Psychopharmacology Real-world data rwd

Updated Expectations are Needed for Masked Priming Experiments: Commentary on Tsikandilakis et al. (2025).

Integrative Psychological and Behavioral Science March 25, 2026 Gary D Fisk

Masking priming research into unconscious perception has a long history of ambiguous findings and controversies. Tsikandilakis and colleagues (2025) offer several commendable methodology recommendations that might resolve ambiguities and lead to compelling findings. However, better methodology might be insufficient to fully address the weaknesses of the null awareness paradigm. The expected...

DOI: 10.1007/s12124-026-09993-0 (opens in new tab) Full text (opens in new tab) Affective primacy hypothesis Cognitive unconscious Consciousness Emotion +4

James Braid and the rise of scientific hypnosis. Review article on the treatise "Neuropnology or justification of nervous sleep in connection with animal magnetism"

ГИПНОЗ И ПСИХОАНАЛИЗ В КЛИНИЧЕСКОЙ И ЭКСПЕРИМЕНТАЛЬНОЙ ПСИХОЛОГИИ March 24, 2026 V. B. Goglidze

The review article of the book by James Braid, "Neuropnology or the rationale of nervous sleep, considered in connection with animal magnetism," is intended to draw attention to the treatise of the outstanding surgeon and hypnologist of the 19th century, who was the first to color the physiological interpretation of the previously mystical method of hypnosis under the monopoly of Mesmerists....

From substance-induced psychosis to schizophrenia: Predictors of treatment response and transition to chronic psychotic illness-A systematic review.

Schizophrenia Research March 24, 2026 Valerio Ricci, Stefania Chiappini, Giovanni Martinotti et al.

Substance-induced psychotic disorders (SIPDs) present significant clinical challenges with variable outcomes. While some patients achieve complete remission following substance cessation, others develop persistent symptoms requiring extended intervention. Understanding treatment response predictors is critical for optimizing clinical management and prognostic accuracy. Following PRISMA...

DOI: 10.1016/j.schres.2026.02.022 (opens in new tab) Full text (opens in new tab) Antipsychotic medication Cannabis psychosis Prognosis Remission predictors +3